Abstract:Background: Diabetes-related osteoporosis (DOP) is a chronic disease caused by the high glucose environment that induces a metabolic disorder of osteocytes and osteoblast-associated mesenchymal stem cells. The processes of bone defect repair and regeneration become extremely difficult with DOP. Adipose-derived stem cells (ASCs), as seed cells in bone tissue engineering technology, provide a promising therapeutic approach for bone regeneration in DOP patients. The osteogenic ability of ASCs is lower in a DOP model than that of control ASCs. DNA methylation, as a mechanism of epigenetic regulation, may be involved in DNA methylation of various genes, thereby participating in biological behaviors of various cells. Emerging evidence suggests that increased DNA methylation levels are associated with activation of Wnt/beta-catenin signaling pathway. The purpose of this study was to investigate the influence of the diabetic environment on the osteogenic potential of ASCs, to explore the role of DNA methylation on osteogenic differentiation of DOP-ASCs via Wnt/beta-catenin signaling pathway, and to improve the osteogenic differentiation ability of ASCs with DOP. Methods: DOP-ASCs and control ASCs were isolated from DOP C57BL/6 and control mice, respectively. The multipotency of DOP-ASCs was confirmed by Alizarin Red-S, Oil Red-O, and Alcian blue staining. Real-time polymerase chain reaction (RT-PCR), immunofluorescence, and western blotting were used to analyze changes in markers of osteogenic differentiation, DNA methylation, and Wnt/beta-catenin signaling. Alizarin Red-S staining was also used to confirm changes in the osteogenic ability. DNMT small interfering RNA (siRNA), shRNA-Dnmt3a, and LVRNA-Dnmt3a were used to assess the role of Dnmt3a in osteogenic differentiation of control ASCs and DOP-ASCs. Micro-computed tomography, hematoxylin and eosin staining, and Masson staining were used to analyze changes in the osteogenic capability while downregulating Dnmt3a with lentivirus in DOP mice in vivo. Results: The proliferative ability of DOP-ASCs was lower than that of control ASCs. DOP-ASCs showed a decrease in osteogenic differentiation capacity, lower Wnt/beta-catenin signaling pathway activity, and a higher level of Dnmt3a than control ASCs. When Dnmt3a was downregulated by siRNA and shRNA, osteogenic-related factors Runt-related transcription factor 2 and osteopontin, and activity of Wnt/beta-catenin signaling pathway were increased, which rescued the poor osteogenic potential of DOP-ASCs. When Dnmt3a was upregulated by LVRNA-Dnmt3a, the osteogenic ability was inhibited. The same results were obtained in vivo. Conclusions: Dnmt3a silencing rescues the negative effects of DOP on ASCs and provides a possible approach for bone tissue regeneration in patients with diabetic osteoporosis.

Tetrahedral Framework Nucleic Acids Enhance Osteogenic Differentiation and Prevent Apoptosis for Dental Follicle Stem Cell Therapy in Diabetic Bone Repair

Tetrahedral Framework Nucleic Acids Promote the Proliferation and Differentiation Potential of Diabetic Bone Marrow Mesenchymal Stem Cell

Bone Marrow Mesenchymal Stem Cells Ameliorated Kidney Fibrosis by Attenuating TLR4/NF-κB in Diabetic Rats.

Synergistic Osteogenic and Antiapoptotic Framework Nucleic Acid Complexes Prevent Diabetic Osteoporosis

Tetrahedral Framework Nucleic Acids Regulate Osteogenic Differentiation Potential of Osteoporotic Adipose-Derived Stem Cells

Effect of Tetrahedral DNA Nanostructures on Proliferation and Osteo/odontogenic Differentiation of Dental Pulp Stem Cells Via Activation of the Notch Signaling Pathway.

Dynamically Bioresponsive DNA Hydrogel Incorporated with Dual-Functional Stem Cells from Apical Papilla-Derived Exosomes Promotes Diabetic Bone Regeneration.

Mitochondria-targeted Drug Delivery System Based on Tetrahedral Framework Nucleic Acids for Bone Regeneration under Oxidative Stress

Effect of Tetrahedral DNA Nanostructures on Osteogenic Differentiation of Mesenchymal Stem Cells Via Activation of the Wnt/β-catenin Signaling Pathway.

Tetrahedral Framework Nucleic Acids’ Role in Facilitating Chronic Diabetic Wound Repair Via the Endoplasmic Reticulum-Mitochondrial Pathway

Tetrahedral Framework Nucleic Acids Prevent Epithelial-Mesenchymal Transition-Mediated Diabetic Fibrosis by Targeting the Wnt/β-catenin Signaling Pathway

Tooth root regeneration using dental follicle cell sheets in combination with a dentin matrix - based scaffold.

Downregulation of DNA Methyltransferase-3A Ameliorates the Osteogenic Differentiation Ability of Adipose-Derived Stem Cells in Diabetic Osteoporosis Via Wnt/-catenin Signaling Pathway

Inflammation-regulated and Nutrient-Supplied Scaffolds Promote Bone Regeneration in Diabetic Microenvironment in Vivo

MiR-26a-tetrahedral framework nucleic acids mediated osteogenesis of adipose-derived mesenchymal stem cells

Diabetic bone regeneration with nanoceria-tailored scaffolds by recapitulating cellular microenvironment: Activating integrin/TGF-β co-signaling of MSCs while relieving oxidative stress

Stem cell secretome restore the adipo-osteo differentiation imbalance in diabetic dental pulp-derived mesenchymal stem cells

Effects of Targeted Delivery of Metformin and Dental Pulp Stem Cells on Osteogenesis via Demineralized Dentin Matrix under High Glucose Conditions

A DNA tetrahedron-based ferroptosis-suppressing nanoparticle: superior delivery of curcumin and alleviation of diabetic osteoporosis

Tetrahedral framework nucleic acids promote diabetic wound healing via the Wnt signalling pathway

Enhancement of Bone Repair in Diabetic Rats with Metformin‐Modified Silicified Collagen Scaffolds